Raygent.com Business Development And Intelligence For Healthcare Markets
  • Home
  • Buzzwords
  • About Us
    • Subscribe
  • Articles
    • Genomic Testing
    • Alzheimer’s Disease
    • Recession Fears trumped by higher crude and supply disruptions
    • 2008 GEN Wall Street RoundUp
    • 2007 Energy Blog
    • Biotech Gen August 2007
    • Biotechnology 2007
    • Cancer Vaccines
    • Emerging Biopharmaceutical
    • Molecular DX
    • Investing in Health Care
    • Diabetes
    • American Society of Clinical Oncology 2005
    • Investing in Biotech
    • Waxman
    • Rag 2005
    • 2009 Biopharmaceutical Portfolio
    • Lockdown-Mode Paralyzes Bioindustry
    • Buzzwords
    • Real Estate Advisory Group 10-09-2005
    • RAG-Real Estate Advisory Group
    • Biopharmaceutical Stock
    • Fidelity Biotech Fund (FBIOX) up 7.9% YTD Outperforms Major ETFs
  • Archives
    • Timeline
  • Contact Us

Find Us Online:

  • BIOgraph
  • Biopharmaceuticals Portfolio
    • 2013 Rayno Biopharmaceuticals Portfolio
  • Diagnostics and Tools Portfolio
    • 2013 Rayno Tools and Diagnostics Portfolio
  • Life Science ETF's and Mutual Funds
    • 2009-2012 Life Science Portfolios
  • Other
    • Company Profiles
    • Energy
    • Macro
    • RAG
    • Weather
  • Reading List

Articles

  • Genomic Testing
  • Alzheimers Disease
  • Recession Fears trumped by higher crude and supply disruptions
  • 2008 GEN Wall Street RoundUp
  • 2007 Energy Blog
  • Biotech Gen August 2007
  • Biotechnology 2007
  • Cancer Vaccines
  • Emerging Biopharmaceuticals
  • Molecular DX
  • Investing in Health Care
  • Diabetes
  • Real Estate Advisory Group 10-9-2005
  • RAG-Real Estate Advisory Group
  • Buzzwords
  • American Society of Clinical Oncology 2005
  • Investing In Biotech
  • Biopharmaceutical Stock
  • Waxman
  • RAG 2005
  • 2009 Biopharmaceutical Portfolio
  • Lockdown-Mode Paralyzes Bioindustry

Share this:

  • Email
  • Print

Search

  • Latest
  • Popular
  • Tags
  • Reversal Day-Caution is Back-NASDAQ Down 1% or 35Pts May 22, 2013
  • When Does the Cost of Cancer Drugs Affect the Market? May 22, 2013
  • Rayno Life Science: Bringing on the Green After a Four Day Rest May 21, 2013
  • Biotechnology Archives: Human Genome Sciences-Anthrax and Lupus May 20, 2013
  • Major Sell-Off in Biopharmaceutical Stocks: Caution and Raise Cash -Update 1 May 16, 2013
  • Rayno Life Science Tools And Dx Portfolio Update:Immucor Beats 6/20 update April 6, 2011
  • Rayno Life Science Portfolio: Dx and Tools Update: Caution March 7, 2011
  • Biomarkers Drive Personalized Medicine May 10, 2010
  • Bulls Better Off with QQQ than Pure Biotech for Now July 19, 2011
  • Rayno 2009 Biotechnology Portfolio-Mid Year Update July 13, 2009
AACC AACC Effect AACR active cellular immunotherapy ADC antibody-drug conjugates Add new tag Alzheimer Disease antibiotics antibody-drug conjugates antisense antiviral ASCO B2-microglobulin BATTLE Trial bearish nat gas market biodiscovery BIO ETF's biogenerics BIOgraph biomarkers biomedical biosimilars Biotech ETF's biotechnology sector biotech portfolios and ETFs biotech stocks C.difficile cancer vaccines immunotherapy clinical diagnostics companion diagnostics diagnostics genomics genomics personalized medicine genzyme GILD HCV healthcare reform Icahn Effect life science ETF's mass spec molecular diagnostics personalized medicine pharmacogenomics targeted therapy venture capital

RSS Reuters Healthcare

  • UPDATE 1-FDA panel says Merck's sleep drug safe, effective at lower dose
  • U.S. Senate committee advances drug compounding bill
  • Shares in NZ's F&P Healthcare jump after record profit
  • NZ's F&P Healthcare FY profit hits record high on strong demand

Subscribe to our blog

Enter your email address below to get all of our posts.


 

About the Author

Rod Raynovich is the founder of Raygent Associates, a management consulting firm providing business development and strategic marketing services in the life science and medical device area. He publishes his thoughts and analysis on the biotech industry at www.raygent.com.

Read More

Raygent Reads

  • Bloomberg – Business & Financial News, Breaking News Headlines
  • GEN | Genetic Engineering & Biotechnology News – Biotech from Bench to Business
  • GenomeWeb
  • Investor Uprising – The Individual Investor Intelligence Network
  • Pullan's Pieces for Drug Partnering
  • ZeroHedge

Copyright © 2009-2012 Raygent.com

Raygent Associates  |  PO Box 3701 Manhattan Beach, CA 90266  |  Phone 1-(310)-871-1231  |  rod@rayno.com

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.